Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MesoPDT: PDT in Multimodal Treatment for Mesothelioma
NCT02662504Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Jan 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of porfimer sodium in malignant pleural mesothelioma (MPM), sponsored by CHU de Lille. Started Jan 2016; status: completed.
02
Drugs
porfimer sodium
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT02662504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662504.